V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002287 | 250005987 | 1.78 | 75.9 | Palliative (P) | 2018-08-02 | 2018-08-02 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | N | ATEZOLIZUMAB | 100041109 |
| 250002290 | 250005988 | 1.87 | 92 | Palliative (P) | 2016-11-06 | 2017-03-30 | null | 02 | N | TIVOZANIB | 100254128 |
| 250002292 | 250005989 | 1.64 | 64 | 03 | null | 2019-03-27 | Pazopanib | 02 | null | CISPLATIN | 101447840 |
| 250002293 | 250005990 | null | null | Palliative (P) | null | 2017-11-19 | null | null | N | ATEZOLIZUMAB | 100462395 |
| 250002295 | 250005992 | null | null | null | null | 2019-07-11 | Trial Unspecified | null | null | IMATINIB | 100590850 |
| 250002296 | 250005993 | 1.66 | 63.05 | Palliative (P) | null | 2018-09-19 | null | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 101098439 |
| 250002302 | 250005995 | 1.78 | null | Palliative (P) | 2020-02-23 | 2020-05-29 | Cisplatin + Pemetrexed | 02 | N | DOCETAXEL | 100341985 |
| 250002303 | 250005996 | 1.87 | 113.3 | null | null | 2019-02-03 | Carboplatin+Fluorouracil 4 or 5 day | 02 | null | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 100982714 |
| 250002305 | 250005998 | 1.31 | 85.2 | Adjuvant (A) | null | 2013-10-23 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | null | AFATINIB | 101639644 |
| 250002308 | 250006001 | 0 | null | null | 2019-09-24 | 2019-10-16 | Carboplatin + Paclitaxel (weekly) | 02 | N | BEVACIZUMAB | 101513232 |
| 250002310 | 250006003 | 1.88 | null | Curative (C) | 2018-07-22 | 2018-08-16 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100066307 |
| 250002312 | 250006004 | 1.1 | 23 | Palliative (P) | 2019-05-11 | 2019-09-04 | PACLITAXEL | 02 | null | EVEROLIMUS + LENVATINIB | 101565576 |
| 250002316 | 250006008 | 1.54 | 61 | null | null | 2019-08-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CARBOPLATIN + PACLITAXEL | 101781046 |
| 250002317 | 250006009 | 1.77 | 81.6 | null | null | 2019-12-02 | null | 02 | null | CABOZANTINIB | 100532326 |
| 250002322 | 250006012 | null | null | null | 2019-10-22 | 2019-10-25 | null | 02 | null | AVELUMAB + AXITINIB | 100624959 |
| 250002326 | 250006014 | 1.55 | 64.65 | null | null | 2018-07-08 | null | 02 | null | CYCLOPHOSPHAMIDE + VINORELBINE | 100452835 |
| 250002327 | 250006015 | null | null | Palliative (P) | null | 2018-05-28 | CAPMATINIB | null | N | CARBOPLATIN + PACLITAXEL | 101013810 |
| 250002328 | 250006016 | 1.71 | 75.1 | Neo-adjuvant (N) | null | 2016-11-12 | null | 02 | null | TRIAL UNSPECIFIED | 101387472 |
| 250002329 | 250006017 | 1.72 | 98.3 | null | 2019-03-24 | 2019-05-05 | null | N | Y | DOCETAXEL | 101560038 |
| 250002331 | 250006019 | null | null | Palliative (P) | 2018-08-29 | 2019-01-21 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN | 100688317 |
| 250002333 | 250006021 | 1.81 | 81 | Curative (C) | 2020-03-07 | 2021-01-10 | null | null | null | CAPECITABINE + OXALIPLATIN | 101519263 |
| 250002334 | 250006022 | 1.71 | 100.6 | 03 | null | 2019-07-17 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | NB BEACON TEMOZOLOMIDE ALONE | 101637139 |
| 250002335 | 250006023 | 1.73 | 23 | 03 | 2020-02-14 | 2020-03-01 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100304734 |
| 250002339 | 250006025 | null | null | Palliative (P) | 2014-08-16 | 2016-04-13 | NB HRNBL-1 Isotretinoin | 01 | null | ATEZOLIZUMAB | 101799261 |
| 250002342 | 250006026 | 1.84 | 98.2 | null | 2019-12-04 | 2019-12-26 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | CARBOPLATIN + PACLITAXEL | 100644136 |
| 250002344 | 250006027 | null | null | null | null | 2017-06-03 | WT SIOP 2002 01 post op Carbo, Etop | N | Y | CARBOPLATIN + FLUOROURACIL | 101069981 |
| 250002348 | 250006029 | 1.69 | 75.4 | null | 2019-02-15 | 2019-02-16 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | GEMCITABINE | 100405765 |
| 250002349 | 250006030 | 1.63 | 76.6 | null | 2018-06-24 | 2018-06-30 | Trial Unspecified | Y | N | ENZALUTAMIDE | 101207029 |
| 250002352 | 250006032 | 1.75 | 0 | Palliative (P) | 2020-01-19 | 2020-01-19 | CAPMATINIB | 02 | null | SUNITINIB | 100092336 |
| 250002355 | 250006033 | 1.63 | 36 | Palliative (P) | 2020-02-14 | 2020-02-25 | VIDE | 02 | null | PACLITAXEL | 100933513 |
| 250002365 | 250006036 | null | null | Palliative (P) | 2018-06-11 | 2018-06-11 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN + FLUOROURACIL | 101127926 |
| 250002373 | 250006038 | 1.55 | 126.6 | null | 2019-02-25 | 2019-03-19 | CARBOPLATIN + PACLITAXEL | 02 | N | ICON8B TRIAL | 100387475 |
| 250002375 | 250006039 | null | null | Palliative (P) | 2022-03-15 | 2022-04-15 | null | 02 | N | ENZALUTAMIDE | 100898708 |
| 250002376 | 250006040 | 0 | 52.2 | Palliative (P) | 2021-04-28 | 2021-05-19 | CARBOPLATIN + RT | 02 | N | ATEZOLIZUMAB | 100497813 |
| 250002380 | 250006041 | null | null | Palliative (P) | 2020-01-06 | 2020-01-20 | null | 02 | N | GEMCITABINE | 101060284 |
| 250002387 | 250006045 | 1.66 | 21 | null | 2017-07-11 | 2017-07-13 | Carboplatin AUC 2 - 5 | 02 | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 100644809 |
| 250002391 | 250006047 | null | null | null | null | 2019-01-19 | GemCarbo Days 1+8 | null | null | BEVACIZUMAB + CARBO + PACLITAXEL | 101434151 |
| 250002393 | 250006048 | 1.69 | 59.1 | Palliative (P) | 2018-05-04 | 2018-05-05 | null | 02 | null | GEMCITABINE | 100413782 |
| 250002396 | 250006049 | null | null | null | null | 2019-06-15 | Paclitaxel 7 day | null | null | PAZOPANIB | 100619159 |
| 250002398 | 250006051 | 0.83 | 14.7 | 03 | 2018-01-31 | 2018-02-11 | null | 02 | N | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 100268931 |
| 250002399 | 250006052 | 1.83 | 60.1 | Palliative (P) | null | 2017-01-02 | null | 02 | N | TRIAL UNSPECIFIED | 100263626 |
| 250002400 | 250006053 | 1.82 | 77.7 | Palliative (P) | 2019-10-09 | 2019-10-28 | Bevacizumab 7.5mg/kg | null | null | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 100654053 |
| 250002402 | 250006054 | null | null | null | null | 2020-01-03 | null | null | N | CARBOPLATIN + PACLITAXEL | 100923309 |
| 250002403 | 250006055 | 1.79 | 57.9 | Palliative (P) | 2019-07-23 | 2019-08-13 | Trial Unspecified | 02 | N | CARBOPLATIN + FLUOROURACIL | 100496582 |
| 250002406 | 250006057 | 0 | 0 | null | null | 2020-04-16 | Dacarbazine | 02 | N | TRIAL UNSPECIFIED | 101384826 |
| 250002409 | 250006060 | 1.54 | 53.9 | null | 2017-03-26 | 2017-04-24 | Docetaxel 75mg/m2 (21 day) | 02 | N | CARBOPLATIN | 100109015 |
| 250002410 | 250006061 | 1.84 | 52.9 | null | 2019-07-08 | 2019-07-08 | Cisplatin + Radiotherapy | N | N | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE | 101773111 |
| 250002411 | 250006062 | null | null | null | null | 2020-01-30 | TEMOZOLOMIDE | null | null | TIVOZANIB | 100395127 |
| 250002412 | 250006063 | 1.57 | 0 | null | 2018-08-01 | 2018-08-03 | Capecitabine + Cisplatin | 02 | N | ATEZOLIZUMAB | 101613599 |
| 250002416 | 250006067 | 1.75 | 28.9 | Palliative (P) | null | 2018-05-21 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 101053374 |